Literature DB >> 18604724

Delays in referral and diagnosis for chronic hematologic malignancies: a literature review.

Gregory A Abel1, Christopher R Friese, Lysa S Magazu, Lisa C Richardson, Maria E Fernandez, Juan Jaime De Zengotita, Craig C Earle.   

Abstract

To better understand the extent of diagnostic and referral delays from primary care providers (PCPs) for chronic hematologic malignancies, causes of these delays, and their possible effects on cancer outcomes, an extensive review of the literature was performed. Over 50 studies were reviewed, including many that concern delays in referral and diagnosis for solid tumors, as there was only sparse literature on delays specific to the liquid tumors. Delays for some chronic hematologic malignancies have been documented, mainly in centralized health care systems. Possible reasons for delays include PCPs' lack of exposure to hematologic malignancies, limited knowledge of associated signs and symptoms, and a reliance on patient symptoms to prompt referral (as opposed to signs and screening). Patient characteristics such as age, gender and race-ethnicity are also likely to play a role, although it is unclear if these exert their effect primarily via patient or provider mechanisms. Unfortunately, the outcomes associated with such delays are largely unreported, possibly because delay is complex to define and difficult to measure.

Entities:  

Mesh:

Year:  2008        PMID: 18604724     DOI: 10.1080/10428190802124281

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  11 in total

1.  Referrals for suspected hematologic malignancy: a survey of primary care physicians.

Authors:  Gregory A Abel; Christopher R Friese; Bridget A Neville; Katherine M Wilson; B Taylor Hastings; Craig C Earle; Nancy L Keating; Lisa C Richardson
Journal:  Am J Hematol       Date:  2012-03-31       Impact factor: 10.047

2.  Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic leukemia.

Authors:  Christopher R Friese; Craig C Earle; Lysa S Magazu; Jennifer R Brown; Bridget A Neville; Nathanael D Hevelone; Lisa C Richardson; Gregory A Abel
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

3.  Diagnostic delay and complications for older adults with multiple myeloma.

Authors:  Christopher R Friese; Gregory A Abel; Lysa S Magazu; Bridget A Neville; Lisa C Richardson; Craig C Earle
Journal:  Leuk Lymphoma       Date:  2009-03

4.  Outcomes for lymphoid malignancies in the Nurses' Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program.

Authors:  Gregory A Abel; Kimberly A Bertrand; Craig C Earle; Francine Laden
Journal:  Hematol Oncol       Date:  2010-09       Impact factor: 5.271

5.  Evaluation of unexplained peripheral lymphadenopathy and suspected malignancy using a distinct quick diagnostic delivery model: prospective study of 372 patients.

Authors:  Xavier Bosch; Emmanuel Coloma; Carolina Donate; Lluís Colomo; Pamela Doti; Anna Jordán; Alfonso López-Soto
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

6.  Decision-making and referral processes for patients with motor neurone disease: a qualitative study of GP experiences and evaluation of a new decision-support tool.

Authors:  Susan Baxter; Christopher J McDermott
Journal:  BMC Health Serv Res       Date:  2017-05-08       Impact factor: 2.655

7.  The impact of structural factors on diagnostic delay in diffuse large B-cell lymphoma.

Authors:  Joanna C Zurko; Raymond C Wade; Amitkumar Mehta
Journal:  Cancer Med       Date:  2019-03-18       Impact factor: 4.452

8.  Presentation and survival in patients with hematologic malignancies in Jos, Nigeria: A retrospective cohort analysis.

Authors:  Ochaka J Egesie; Patricia A Agaba; Olugbenga A Silas; Chad Achenbach; Ayuba Zoakah; Oche O Agbaji; Jeremiah A Madaki; Edith N Okeke; Lifang Hou; Atiene S Sagay; Robert Murphy
Journal:  J Med Trop       Date:  2018-05-29

9.  Understanding quality and equity: patient experiences with care in older adults diagnosed with hematologic malignancies.

Authors:  Alex Fauer; Sung Won Choi; Lauren P Wallner; Matthew A Davis; Christopher R Friese
Journal:  Cancer Causes Control       Date:  2021-02-10       Impact factor: 2.506

10.  Diagnostic testing managed by hematopathology specialty and other laboratories: costs and patient diagnostic outcomes.

Authors:  Nicole M Engel-Nitz; Benjamin Eckert; Rui Song; Priyanka Koka; Erin M Hulbert; Jeffrey McPheeters; April Teitelbaum
Journal:  BMC Clin Pathol       Date:  2014-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.